Related references
Note: Only part of the references are listed.Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-
Gian Paolo Caviglia et al.
HEPATOLOGY RESEARCH (2017)
Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
Natthaya Chuaypen et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Ching-Lung Lai et al.
JOURNAL OF HEPATOLOGY (2017)
Baseline HBsAg and HBcrAg titres allow peginterferon-based precision medicine' in HBeAg-negative chronic hepatitis B patients
M. Martinot-Peignoux et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
B. Maasoumy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion During Treatment With Polymerase Inhibitors
Florian van Boemmel et al.
HEPATOLOGY (2015)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers
Simon B. Larsson et al.
LIVER INTERNATIONAL (2014)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
Tai-Chung Tseng et al.
HEPATOLOGY (2013)
Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation
Toshihisa Matsuzaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Akihiro Matsumoto et al.
HEPATOLOGY RESEARCH (2012)
Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection
Rahmet Guner et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Relationship Between Serum Hepatitis B Virus DNA and Surface Antigen With Covalently Closed Circular DNA in HBeAg-Negative Patients
L. Y. Lin et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B Patients
Fumitaka Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection
Danny Ka-Ho Wong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Low serum level of hepatitis B indicates unlikely reactivation core-related antigen of hepatitis after cessation of lamivudine therapy
Akihiro Matsumoto et al.
HEPATOLOGY RESEARCH (2007)
Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection
Noboru Shinkai et al.
HEPATOLOGY RESEARCH (2006)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance
E Tanaka et al.
LIVER INTERNATIONAL (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
T Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients
DKH Wong et al.
HEPATOLOGY (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
A Rokuhara et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Share Paper
